Study of histomorphological patterns of salivary gland tumors

---

Original Article

Author Details : Kishan Bookya, Raghuram Mohan

Volume : 5, Issue : 1, Year : 2018

Article Page : 92-96

https://doi.org/10.18231/2394-6792.2018.0017

Suggest article by email

Get Permission

---

Abstract

Introduction: Salivary gland neoplasms though relatively rare, have a varied histological spectrum both in the benign and malignant tumors and hence, are of interest to pathologists.
Aim of the study: To study the histomorphological patterns of salivary gland tumors.
Materials and Methods: This was a two year four month prospective study from January 2015 to April 2017. The salivary gland specimens received in histopathology section of Department of Pathology, Government Medical College, Nizamabad, Telangana were studied for light microscopy.
Results: Present study included 80 cases, with patient age ranging from 11 to 78 years and the male to female ratio was 3:1. In the present study 62.5% cases were benign and 37.5 % were malignant. Pleomorphic adenoma was the commonest benign tumor followed by Warthin’s tumor, monomorphic adenoma and basal cell adenoma. Mucoepidermoid carcinoma was the most common malignant tumor followed by adenoid cystic carcinoma, acinic cell carcinoma and carcinoma ex pleomorphic adenoma.
Conclusion: Of all salivary glands, Parotid glands are most commonly affected by tumors. Pleomorphic adenoma is the most common benign tumor and Mucoepidermoid carcinoma is the most common malignant tumor in salivary glands.

Keywords: Mucoepidermoid Carcinoma, Pleomorphic adenoma, Salivary gland tumors.

How to cite : Bookya K, Mohan R, Study of histomorphological patterns of salivary gland tumors. Indian J Pathol Oncol 2018;5(1):92-96

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.